Clin2
NCT05916469Possibly a fitRecruiting

Hormone treatment for heavy periods in teens and young adults

Heavy Menstrual BleedingBleeding DisorderVon Willebrand Diseases

Part of Blood & lymphatic, Genetic & congenital, Heart & circulation, Women’s health & pregnancy clinical trials.

This trial studies how a progestin hormone—given as an IUD or tablets—can help reduce heavy menstrual bleeding in people with certain bleeding-related conditions. It may help you by testing whether the treatment works and is practical for your situation.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
10 years to 24 years
Study type
Observational

Who can take part

  • You have started menstruation and are between ages 10 and 24
  • You and your clinician are planning to try progestin treatment (either an LNG IUD or NETA pills)
  • Your periods fit the trial definition of heavy menstrual bleeding
  • You have a known bleeding disorder or are willing/able to complete a basic check to rule one out
  • If you’re under 18, a parent can provide consent and you can provide assent; if 18+, you provide consent

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06740929Recruiting
Hormonal treatment for heavy periods in teens

This study tests whether different types of hormonal medication (such as pills or an intrauterine device) can help manage heavy periods in adolescents and young adults. The goal is to find what works best for reducing bleeding and improving quality of life.

Geneva
NCT06671548Recruiting· Phase 3
Study of relugolix for heavy periods from uterine fibroids

This trial tests if relugolix can reduce heavy menstrual bleeding caused by uterine fibroids. It may be an option for women who want to avoid surgery.

Beijing
NCT07326722Recruiting
Study of tAN device for heavy menstrual bleeding

This study tests whether a small nerve stimulation device (tAN) worn on the ear can help reduce heavy menstrual bleeding. You will use the device during your periods and track your bleeding with provided products and an app.

Boston, Massachusetts
NCT05444582Recruiting· Phase 4
52 mg hormonal IUD placed for emergency or same-day birth control

This study checks whether placing a 52 mg hormonal IUD soon after sex (up to 5 days) or on the same day (under certain timing) is safe and works as birth control. You may be able to join if you need emergency contraception or want to start an IUD right away and meet clinic and pregnancy-safety checks.

San Jose, California
NCT07734155Not yet recruiting· Phase 3
Testing a vaginal hormone system for birth control

This trial tests a hormone-releasing vaginal system for birth control in women who can become pregnant. It may help prevent pregnancy safely and effectively.

NCT05862805Recruiting· Phase 1/Phase 2
Testing treatments affecting uterine bleeding during periods

This early-stage study tests medicines that may help control heavy uterine bleeding by changing how blood clots work in the uterus. If you have regular periods and meet the setup rules, you may be asked to provide menstrual tracking and undergo an endometrial (uterine lining) biopsy.

Portland, Oregon

Hear when a new Heavy Menstrual Bleeding trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.